Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations (CERC)

Mayo Clinic

Status: Completed

Conditions: Vaccine Preventable Disease

Treatments: Other: Educational, culturally appropriate COVID-19 messages

Study type: Interventional

Funder types: Other

Identifiers

NCT04765839

21-000205

Details and patient eligibility

About

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Full description

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Enrollment: 74 patients

Sex: All

Ages: 18 to 101 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Self-identification within a CLs social network
• Age 18 or greater
• Functional internet access.

Exclusion criteria

• Does not self-identify within a CLs social network
• Is under the age of 18
• Does not have functional internet access.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

74 participants in 2 patient groups

Intervention Arm - Receives COVID-19 Vaccine messages

Experimental group

Description:

Group to receive COVID-19 Vaccine messages during the first two weeks of the study.

Treatment:

Other: Educational, culturally appropriate COVID-19 messages

Delayed Intervention Arm

Experimental group

Description:

Group to receive COVID-19 Vaccine messages during the last two weeks of the study.

Treatment:

Other: Educational, culturally appropriate COVID-19 messages